COSMETIC / DIRECT CATALOG PRICING
GHK-Cu
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). The catalog name does not identify counterion, copper stoichiometry, or analytical specification.
- Format
- Lyophilized research vial
- Listed formats
- 2
- Available now
- 2
- Catalog class
- Cosmetic
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). The catalog name does not identify counterion, copper stoichiometry, or analytical specification.
The cosmetic classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Cosmetic
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- 2 formats currently orderable
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). The catalog name does not identify counterion, copper stoichiometry, or analytical specification.
- Research covered
- A guinea-pig skin-wound and cultured-fibroblast study evaluated GHK-copper and related copper complexes, measuring histology, collagen-associated markers, and fibroblast responses. This is animal and cell-model evidence, not a clinical study of the catalog material.
- Important limit
- The cited work does not verify this vendor lot, the catalog's 50 mg or 200 mg presentations, purity, or outcomes in people. GHK and GHK-Cu must not be treated as interchangeable without compound-specific documentation.
- Authoritative sources
FACTUAL FAQ
GHK-Cu catalog questions
What formats are currently listed?
50 mg, 200 mg. Current price and stock state appear above.
What did researchers study?
A guinea-pig skin-wound and cultured-fibroblast study evaluated GHK-copper and related copper complexes, measuring histology, collagen-associated markers, and fibroblast responses. This is animal and cell-model evidence, not a clinical study of the catalog material.
What is the most important evidence limit?
The cited work does not verify this vendor lot, the catalog's 50 mg or 200 mg presentations, purity, or outcomes in people. GHK and GHK-Cu must not be treated as interchangeable without compound-specific documentation.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
